StockData
Mangoceuticals, Inc. logo

Mangoceuticals, Inc. (MGRX) stock

MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$0.15−0.01 (-8.44%)

Close on Nov 18, 2026Market cap $3.16MP/E –Yield –

Mangoceuticals shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Mangoceuticals's shares outstanding was 17M at Jun 30, 2026. For fiscal 2025 it was 10M, up 408.9% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202510M+408.9%
FY2024Dec 31, 20242M+84.2%
FY2023Dec 31, 20231M+49.2%
FY2022Dec 31, 20221M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202617M+71.5%
Q1 FY2026Mar 31, 202616M+258.8%
Q4 FY2025Dec 31, 202514M+441.4%
Q3 FY2025Sep 30, 202512M+472.3%
Q2 FY2025Jun 30, 202510M+473.8%
Q1 FY2025Mar 31, 20255M+191.7%
Q4 FY2024Dec 31, 20243M+99.7%
Q3 FY2024Sep 30, 20242M+89.7%
Q2 FY2024Jun 30, 20242M+65.5%
Q1 FY2024Mar 31, 20242M+109.8%
Q4 FY2023Dec 31, 20231M+46.3%
Q3 FY2023Sep 30, 20231M+58.5%
Q2 FY2023Jun 30, 20231M+75.1%
Q1 FY2023Mar 31, 20231M+40.7%
Q4 FY2022Dec 31, 20221M–
Q3 FY2022Sep 30, 20221M–
Q2 FY2022Jun 30, 20221M–
Q1 FY2022Mar 31, 20221M–

More Mangoceuticals figures

See a number that looks wrong?